Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Ulcerative Colitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06109441
What this trial is testing

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

Who this might be right for
Ulcerative Colitis
AltruBio Inc. 50
Very early researchNot Yet RecruitingNCT06853522
What this trial is testing

HucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Shanghai East Hospital 40
Large-scale testing (Phase 3)Study completedNCT04505410
What this trial is testing

Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Miami 32
Large-scale testing (Phase 3)Study completedNCT03518086
What this trial is testing

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,281
Post-approval studies (Phase 4)Not Yet RecruitingNCT04999241
What this trial is testing

Combined Application of EEN in the Induction of Remission in PUC

Who this might be right for
Exclusive Enteral NutritionUlcerative ColitisChildren
Children's Hospital of Fudan University 40
Testing effectiveness (Phase 2)Study completedNCT02888379
What this trial is testing

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Topivert Pharma Ltd 77
Testing effectiveness (Phase 2)Looking for participantsNCT06453317
What this trial is testing

Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisInflammatory Bowel Diseases
Medical University of Lodz 172
Early research (Phase 1)Looking for participantsNCT07665723
What this trial is testing

An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

Who this might be right for
Active Ulcerative Colitis
Hoffmann-La Roche 25
Large-scale testing (Phase 3)Ended earlyNCT03259308
What this trial is testing

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shire 279
Early research (Phase 1)Ended earlyNCT02000453
What this trial is testing

Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 2
Testing effectiveness (Phase 2)Study completedNCT03494764
What this trial is testing

Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares

Who this might be right for
Colitis, Ulcerative
Dartmouth-Hitchcock Medical Center 39
Not applicableStudy completedNCT05791526
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

Who this might be right for
Ulcerative Colitis
AbbVie 308
Early research (Phase 1)Study completedNCT01900574
What this trial is testing

Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 35
Testing effectiveness (Phase 2)Ended earlyNCT05785715
What this trial is testing

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 81
Large-scale testing (Phase 3)Ended earlyNCT00537316
What this trial is testing

Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)

Who this might be right for
Ulcerative Colitis
Merck Sharp & Dohme LLC 242
Large-scale testing (Phase 3)Study completedNCT05767021
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 172
Large-scale testing (Phase 3)Active Not RecruitingNCT04624230
What this trial is testing

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 118
Large-scale testing (Phase 3)Ended earlyNCT03259334
What this trial is testing

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shire 380
Testing effectiveness (Phase 2)Study completedNCT00616434
What this trial is testing

Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Who this might be right for
Active Ulcerative Colitis
Biogen 123
Very early researchNot Yet RecruitingNCT07353450
What this trial is testing

Cizutamig for Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Ruijin Hospital 15
Next Page